HIT Consultant July 10, 2020
What You Should Know:
– Repurpose.AI, has partnered with Scripps Research to discover drug candidates that may be repurposed to treat COVID-19.
– The partnership will leverage Repurpose.AI’s ActivPred AI Drug Discovery Platform, an unbiased drug, target, and disease agnostic digital chemistry engine, to discover drug candidates to treat COVID-19.
Scripps Research is teaming up with Repurpose.AI, an AI drug discovery company to develop COVID-19 therapeutics. The partnership will leverage Repurpose.AI’s ActivPred AI Drug Discovery Platform, an unbiased drug, target, and disease agnostic digital chemistry engine, to discover drug candidates to treat COVID-19. Previously, the company has successfully utilized the platform to discover REP-001, REP-002, and REP-003 – three Phase II/III ready small molecule assets for the treatment...
Today's Sponsors
Today's Sponsor